Viewing Study NCT01195857


Ignite Creation Date: 2025-12-24 @ 7:04 PM
Ignite Modification Date: 2026-02-01 @ 9:05 AM
Study NCT ID: NCT01195857
Status: COMPLETED
Last Update Posted: 2014-02-04
First Post: 2010-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple sclerosis View
None Rebif View
None Interferon beta-1a View